Syneos Health predicts pharma trends leaping forward in 2023 after reboot year
Is 2023 finally the year for artificial intelligence to go prime time in biopharma? That’s the prediction, along with a slate of others, out today from Syneos Health in its annual trends report.
Technology and data loom large in its forecast with AI, digital transformations, local market uptake, the growth of “age tech” and a general rethinking about the digital effect on everyday health and healthcare decisions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.